OOIR: Observatory of International Research

Papers

(The H4-Index of American Journal of Psychiatry is 49. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Highlights From the Residents’ Journal: December 2021	519
Treating Pathologies of the Will	223
Integrating Clinical and Basic Research: Opioid Use Disorder, Psychotic Illnesses, and Prefrontal Microcircuits Relevant to Schizophrenia	160
Evaluating Associations Between Cannabis and Heroin Use	149
Broadening the Parameters of Clinical High Risk for Psychosis	139
2024 Annual Meeting: Presidential Address	131
Effectiveness of Antipsychotic Use for Reducing Risk of Work Disability: Results From a Within-Subject Analysis of a Swedish National Cohort of 21,551 Patients With First-Episode Nonaffective Psychosi	125
Future of Sensorimotor and Psychomotor Dysfunction in Mental Disorders: Emerging Tools, Methodological Challenges, and the Road Ahead	124
A Call to Psychiatrists: Deprescription of Unnecessary Anticholinergic Medications in Schizophrenia Must Start Now	122
20-Year Prospective, Sequential Follow-Up Study of Heterogeneity in Associations of Duration of Untreated Psychosis With Symptoms, Functioning, and Quality of Life Following First-Episode Psychosis	111
A New Agenda for Optimizing Investments in Community Mental Health and Reducing Disparities	103
From Scanner to Bedside: Building Bridges in Translational Psychiatric Neuroimaging	102
Brain-Based Biotypes of Psychiatric Vulnerability in the Acute Aftermath of Trauma	102
Depression, Inflammation, and Postpartum Psychosis	101
From Prediction to Action: Moving Beyond Machine Learning to Implementing Evidence-Based Perinatal Mental Health Care	99
Neural Signatures of Pain Modulation in Short-Term and Long-Term Mindfulness Training: A Randomized Active-Control Trial	93
Cannabis and Brain Health: What Is Next for Developmental Cohort Studies?	91
Can Neuromelanin-Sensitive MRI Provide Insight Into the Dopaminergic Pathways Contributing to Substance Use?	86
Predicting Conversion to Psychosis: What Lies Beyond the Biomarkers?	86
Mental Health Disparities Research: An Introduction to New Directions	85
Intentional Drug Overdose Deaths in the United States	82
Project Harmony: A Meta-Analysis With Individual Patient Data on Behavioral and Pharmacologic Trials for Comorbid Posttraumatic Stress and Alcohol or Other Drug Use Disorders	80
On the Genetic and Environmental Relationship Between Suicide Attempt and Death by Suicide	77
Correcting Overestimations in Self-Harm Visit Data	74
Genes To Mental Health (G2MH): A Framework to Map the Combined Effects of Rare and Common Variants on Dimensions of Cognition and Psychopathology	74

Suicide and the Menstrual Cycle	72
An Innovative Approach to Extending the Antidepressant Effects of Intravenous Ketamine in Major Depression	68
Methamphetamine-Induced Psychosis and Schizophrenia: A Call for Special Attention: Response to Zhu et al.	68
Correction to Poirot et al.	67
Corrigendum to Morley et al.	64
Older Adults are at Heightened Risk of the Effects of Cannabis Use: Response to Walaszek	61
Familial Risk of Postpartum Psychosis	61
New Insights Into Psychotic Disorders	61
2024 Annual Meeting: CEO and Medical Director’s Address	61
Back to the Future: Esmethadone, the (Maybe) Nonopiate Opiate, and Depression	59
Highlights From the Residents’ Journal: September 2024	59
Coordinate Network Mapping: An Emerging Approach for Morphometric Meta-Analysis	58
Neural Responses to Intranasal Oxytocin in Youths With Severe Irritability	58
Trends in Prescription Stimulant, Opioid, and Benzodiazepine Use and Diversion in U.S. Adolescents	56
The First Large GWAS Meta-Analysis for Postpartum Depression	56
Similar Rates of Deleterious Copy Number Variants in Early-Onset Psychosis and Autism Spectrum Disorder	55
Reduced Threat-Related Neural Efficiency: A Possible Biomarker for Pediatric Anxiety Disorders	55
Schizophrenia Imaging Signatures and Their Associations With Cognition, Psychopathology, and Genetics in the General Population	54
Sensitivity of Schizophrenia Endophenotype Biomarkers to Anticholinergic Medication Burden	53
Reduced Brain Responsiveness to Emotional Stimuli With Escitalopram But Not Psilocybin Therapy for Depression	53
12-month Prevalence Estimates of Substance Use Disorders Using DSM-5 Versus DSM-IV Criteria Among U.S. Nonelderly Adults With Substance Use	53
Characterizing the Most Vulnerable Prefrontal Cortical Neurons in Schizophrenia	53
Durability of Effects of Cognitive Remediation on Cognition and Psychosocial Functioning in Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Clinical Trials	52
Stanford Neuromodulation Therapy (SNT): A Double-Blind Randomized Controlled Trial	50